{"name":"C4 Therapeutics, Inc.","slug":"c4-therapeutics-inc","ticker":"","exchange":"","domain":"c4therapeuticsinc.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CFT1946","genericName":"CFT1946","slug":"cft1946","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"CFT1946","genericName":"CFT1946","slug":"cft1946","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQU0Y3bHBvcmtGa2JrT0VRbFk5QmxfSXlXRkd1a1R4MEZ5Q3hISGlLX21uRWxzc21qYUxJQVU3ZkJ4cEdHYm91TzJ3eG1hUnB2am9tSVJXZVB6bmhJVlhFcmQwSlAwMjZUZVFGNU1kdDRNZWNmcDdHazI3Z255QWlGZlg3WW4ycno3emRjai10RG00dkpKM251UUZEOA?oc=5","date":"2026-03-09","type":"trial","source":"finviz.com","summary":"C4 Therapeutics (CCCC) Well Positioned With Cemsidomide Trial Data - finviz.com","headline":"C4 Therapeutics (CCCC) Well Positioned With Cemsidomide Trial Data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPbHFjSjYyQlJXUzY0cjljR3lIQkMyUVRFZGVoOGFWMFpRSUJ2N0FYNVVSam8wYjFBWnFibl94Qnd5TEtiX1JENVhnalhlQTFmSWlBVURmTUQ5bDBkR0VfWDBkM2M2RzFzUXB1NlZBcXdwYjhCWnAxZEdVRFdYVi1mU0xwa2dNQkZPbzVsYm15YjdCWlZiVXRXcjlLUUVmQQ?oc=5","date":"2026-02-26","type":"pipeline","source":"TradingView","summary":"C4 Therapeutics, Inc. SEC 10-K Report - TradingView","headline":"C4 Therapeutics, Inc. SEC 10-K Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE1HN0FRZ282UjVabnNjVl9JV0p6R1p4a3FObFY5NHRqVkltaUFEblRqaFpEWUdYMm5oODdZME93SUFtM1JlLXVuOGZyMXRscTNmN1o1dEdTV0t2dEtmWUhpZlRMNzNBZXRhS05aRlpHSkNzYkRKZ1ItcGdUd1o?oc=5","date":"2026-02-24","type":"trial","source":"StocksToTrade","summary":"Brookline Raises C4 Therapeutics Price Target Amid Trial Confidence​ - StocksToTrade","headline":"Brookline Raises C4 Therapeutics Price Target Amid Trial Confidence​","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-10","type":"pipeline","source":"simplywall.st","summary":"Institutional investors may adopt severe steps after C4 Therapeutics, Inc.'s (NASDAQ:CCCC) latest 11% drop adds to a year losses - simplywall.st","headline":"Institutional investors may adopt severe steps after C4 Therapeutics, Inc.'s (NASDAQ:CCCC) latest 11% drop adds to a yea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNcldlbkdYLXJWYjItMTlWSy05VHVuUnliNEsyYVBnYnVneEpnS0hGaHVNWDYyZ1plbmVPRGJDZUJmWm9Ma1RrWlF6WWdrU0otajJmTFB0NlB4Y3Vfd1MxSnptNmZjM3JiSVhrUVB1VHhhcjBJZ1pqTWc4VTR1U1ZQZg?oc=5","date":"2026-02-02","type":"pipeline","source":"Yahoo Finance","summary":"C4 Therapeutics, Inc. (CCCC): A Bull Case Theory - Yahoo Finance","headline":"C4 Therapeutics, Inc. (CCCC): A Bull Case Theory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPTGZoRHM2UEpySnZaWklxV1V5bkltSkgwT1g3Wk93cURvNjY3MDM5YXdzUXJoM25Jb0ZjY0dHaFhIVE5rWXh2cGdsN0RxWURuaHZnOWU0aU5ldG1DQXJNNS1VUmxXM2dzS3BvQU9iRlBCY1NTRy1LRFJ0TjBYQ1VvdkV1VXhteGdFbmg4XzRhUlR4YklXZU9pWUZNeFJEYmdaTXk1LVZZemtYdw?oc=5","date":"2026-01-14","type":"pipeline","source":"Bloomberg Law News","summary":"NJ Pharma Consultant Hit With SEC, DOJ Insider Trading Charges - Bloomberg Law News","headline":"NJ Pharma Consultant Hit With SEC, DOJ Insider Trading Charges","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-17","type":"pipeline","source":"simplywall.st","summary":"Insufficient Growth At C4 Therapeutics, Inc. (NASDAQ:CCCC) Hampers Share Price - simplywall.st","headline":"Insufficient Growth At C4 Therapeutics, Inc. (NASDAQ:CCCC) Hampers Share Price","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPbjlacXp4Z0UxRkZFTkdZZGJaN2hhLTNLamVZdG0wTlJ0SElCRzJmck1YMVRQQl9YbGs0YkF6R3hRaXlxc3VTanVweTVES0pPZUl2ZzgtR1NoeVBBQ1I1LXprXzhoblJwTzlmdThUVFY3MHFWbXI1aWIyVlFZZ1RPRzBKXzltVW4zQ05xUENsLWhTZjNQdjBScERvOVVaMjRMRHBGaktpcm1GR29PVlU0MEk3dk9mOVNzUVNKU1FjU3ZpNms?oc=5","date":"2025-10-30","type":"deal","source":"GuruFocus","summary":"RA CAPITAL MANAGEMENT, L.P. Acquires Significant Stake in C4 The - GuruFocus","headline":"RA CAPITAL MANAGEMENT, L.P. Acquires Significant Stake in C4 The","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNWjlVd0JoZXRjMmxrak9Tclh2aHpfMDkyWHYza1l3bF9VXzdkc2lsM0lLZTRsYUZsZTg1VV94Nl8xXzE5cDBWY2E3Y2NCbl9FMDRMYU5ZSHpRYXl1REhvalQ3alpLbFBFNUlianJRTDd4SXV5SzBXNDhhRUtnSkNpTEFiWWVHeVp0X3ZRQThFMHdJRjdQcVZjTW4zbkpxUQ?oc=5","date":"2025-10-16","type":"pipeline","source":"Investing News Network","summary":"C4 Therapeutics Announces Pricing of $125 Million Underwritten Offering - Investing News Network","headline":"C4 Therapeutics Announces Pricing of $125 Million Underwritten Offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPeGRFZmNGWU1lRUNzQmR0UDlEVjhjTWZxX3luLWN4bmFoa3lxakJEOHhfOTNqT01YQ3ByeVNIS3ZIQmxpT1ZNZGVZeUk5TlBYR0RfOUdFR3NDOG5YcmhQazhLaGE1aHdXZkFBSVJ2ZTVSTTZKYnNNeEJ4eWRVS3FLenhhek45ZlhEUXBncE1qZ0ZxYWJreXBpNFg1WTBsM1NJb2c?oc=5","date":"2025-05-07","type":"pipeline","source":"Fierce Biotech","summary":"C4 Therapeutics halts BRAF degrader work to save cash for cemsidomide - Fierce Biotech","headline":"C4 Therapeutics halts BRAF degrader work to save cash for cemsidomide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOR3hHVHo1cmNnTUF4Y2lQYW8wQUdkVWhFbEZjZS1FSHdTeGZaR1dOWXN1Sy1UWXpMQUVLcDhSd0F4TU15WXJRTThnY0ZBMGFneDBWTXVObmdIczFydVNKbURlN29Hc2l5Y2x4QlpQTGR0TUM3RUpocm9CZ1daMzZJa2Q5dnVaVDVnZzZIRkp2OGV0empVQUxDeU41OGpmTF9JczBn?oc=5","date":"2025-03-10","type":"pipeline","source":"Investing.com","summary":"C4 Therapeutics stock hits 52-week low at $2.21 - Investing.com","headline":"C4 Therapeutics stock hits 52-week low at $2.21","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-05-30","type":"pipeline","source":"GlobeNewswire","summary":"C4 Therapeutics and Betta Pharmaceuticals Announce - GlobeNewswire","headline":"C4 Therapeutics and Betta Pharmaceuticals Announce","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}